CompletedPHASE1, PHASE2NCT00147368

Arginine Malaria Trial: Study of Adjunctive Arginine in Falciparum Malaria

Studying Malaria

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Menzies School of Health Research
Principal Investigator
Nick M Anstey, MBBS
MSHR
Intervention
intravenous (IV) arginine(drug)
Enrollment
50 target
Eligibility
18-60 years · All sexes
Timeline
2005 – 2007

Study locations (1)

Collaborators

Wellcome Trust · National Health and Medical Research Council, Australia · MSHR · National Institute of Health Research and Development, Ministry of Health Republic of Indonesia · Rumah Sakit Mitra Masyarakat Hospital · University of Utah · University of Sydney

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00147368 on ClinicalTrials.gov

Other trials for Malaria

Additional recruiting or active studies for the same condition.

See all trials for Malaria →

← Back to all trials